The Scientist Trying to Keep Kratom Legal Has Not Disclosed Longstanding Ties to Kratom Lobbyists

Read the original at ProPublica ↗
Cite

Damon, A. (2026, September 3). The Scientist Trying to Keep Kratom Legal Has Not Disclosed Longstanding Ties to Kratom Lobbyists. ProPublica. https://www.propublica.org/article/kratom-legalization-christopher-mccurdy-research-conflict-of-interest-aka

Dated when The Aporia collected the article, usually within hours of publication. Check the original for its exact date and byline.

ProPublica · collected 2026-09-03 · by Anjeanette Damon

Quick Summary

A University of Florida professor, Christopher McCurdy, is accused of failing to disclose financial ties to the American Kratom Association (AKA), a powerful lobbying group that advocates for keeping kratom legal. According to documents, McCurdy has accepted travel reimbursements and funding from AKA without disclosing it in his conflict of interest statements or research papers. The article reports that 5,200 people died from kratom-related overdoses between 2020 and 2024, with calls to poison control centers involving kratom spiking 1,200% over the last decade. McCurdy has built a reputation as a neutral expert on kratom, but his lack of disclosure and contradictory research findings have raised questions about his credibility in the debate over kratom's safety and regulation.
Written locally by qwen2.5:14b on 2026-09-03, using this article's own text rather than the other coverage of the same event (that is the story summary below).

AI analysis runs on qwen2.5:14b, locally

Story summary

University of Florida professor Christopher McCurdy, who is urging policymakers not to ban kratom, a substance linked to 5,200 deaths in the US between 2020 and 2024, has failed to disclose his longstanding financial ties to the American Kratom Association, a powerful lobbying group. The association has provided him with travel reimbursements, donations to his university's foundation, and funding for an annual symposium on kratom research. This lack of disclosure has raised concerns about potential conflicts of interest. Meanwhile, the fight to keep kratom legal has intensified as more potent derivatives appear in stores and evidence mounts of its health risks.

Written for “Kratom Legality Challenges Continue” on 2026-10-19, grounded in this article and the 0 other(s) covering the same event.

Story

📰 Kratom Legality Challenges Continue
Crime & Law · 1 article(s) covering the same event.

Compared with similar articles

This article reads unscored and hedges 7% of its claims. Each row says how that neighbour differs.
ProPublica
⚖️ Leans strongly left 🔴 9% hedged 14 of 148 📰 publisher trust 96
“The articles cover different topics and incidents: one is about kratom lobbyists, the other is about marijuana regulators and product safety.”
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
104
sentences that state something as happening or true
Uncertain
7%
7 of 104 hedged ("reportedly", "may", "according to")
Leaning
withheld
no quote in the article backed the model's score
Publisher signals
96/100
ProPublica's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
1
Crime & Law
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-09-03 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

ProPublica · 95 article(s) · 0 correction(s) detected
No corrections detected for this publisher. That may mean careful reporting, or simply that nothing has been checked.

Who wrote this

Anjeanette Damon
1 article(s) here · 1 carrying a prediction
🔮 Such funding could be disrupted if kratom is declared illegal.
The only article under this byline in the corpus.

Topics

ProPublica University of Florida the American Kratom Association the Centers for Disease Control and Prevention the United States

Subjects

McCurdy PERSON · 8× ProPublica ORG · 3× the American Kratom Association ORG · 2× America GPE · 1× Christopher McCurdy PERSON · 1× D.C. GPE · 1× University of Florida ORG · 1× Washington GPE · 1× the Centers for Disease Control and Prevention ORG · 1× the United States GPE · 1×

Narrative

Regarding McCurdy’s lack of disclosure that the association funds his travel, Haddow contends that beneficiaries aren’t typically required to reveal travel-related payments and said the association has never commissioned a study from McCurdy that would require disclosure. Instead, the group has donated to the University of Florida’s foundation and has helped to underwrite McCurdy’s annual kratom symposium, attended by about 100 scientists, to promote research into kratom’s therapeutic potential.
framing: assertive · carried by 1 article(s) · first seen 2026-09-03
🔮 Such funding could be disrupted if kratom is declared illegal.

Claims (104 extracted, 7 hedged)

The leading scientist urging policymakers not to criminalize kratom, a substance that has left a trail of death and addiction around the world, has routinely failed to disclose longstanding financial ties to the industry’s most powerful lobbying group, ProPublica has found. asserted
ProPublica → lead → group
University of Florida professor Christopher McCurdy has accepted travel reimbursements, donations to his university’s foundation and funding for an annual symposium on research into the leaf’s medicinal potential from the American Kratom Association — none of which has been disclosed in his conflict of interest statements or on the papers he publishes. asserted
he → accept → papers
The fight to keep kratom legal across the country has taken on increased urgency as more potent kratom derivatives have appeared on store shelves and evidence has mounted of the leaf’s risks to users’ health. asserted
evidence → keep → health
According to the Centers for Disease Control and Prevention, 5,200 people in the United States died from drug overdoses involving kratom between 2020 and 2024. uncertain
people → accord → 2020
And calls to poison control centers involving kratom have spiked 1,200% in the last decade. asserted
calls → involve → decade
The lobbying group, which says it advocates for kratom consumers, has waged a pitched battle in statehouses and in Washington, D.C., to keep kratom products widely available in America’s gas stations, smoke shops and convenience stores. asserted
it → say → stations
Documents show it has relied repeatedly on McCurdy to help convince lawmakers kratom is safe enough to remain legal — deploying him to key states that are either considering full bans on the leaf or are on the verge of overturning an existing ban. asserted
that → show → ban
His success fighting federal regulators earned him a place in the AKA’s Legacy Advocate Hall of Fame. asserted
success → fight → Fame
Kratom comes from a tree native to Southeast Asia and is sold as a powder or in capsules, tablets or shots like energy drinks. asserted
Kratom → come → drinks
In small amounts, it acts as a stimulant. asserted
it → act → stimulant
In larger amounts, it acts like an opioid. asserted
it → act → opioid
Although the Food and Drug Administration prohibits marketing it as a supplement or using it as a food ingredient, it’s advertised as a mood and energy enhancer, a painkiller and an alternative to opioids. asserted
it → prohibit → opioids
ProPublica’s review of McCurdy’s appearances in recent years shows he has emphasized kratom’s therapeutic potential while downplaying its risks — despite his own published research finding kratom use can lead to severe withdrawal symptoms in newborns exposed in utero, and to dependency and even death in those who take it. asserted
who → show → it
McCurdy has brushed off questions about the hazards by noting that even water can kill if consumed in excessive quantities. asserted
water → brush → quantities
McCurdy does, however, argue for better manufacturing standards and labeling, and for putting age restrictions on kratom’s use. asserted
McCurdy → argue → use
Other scientists who consult with and do research for the kratom association disclose that relationship. asserted
who → consult → relationship
But McCurdy, who does not disclose it, has built a reputation as a neutral arbiter in the emotional debate pitting those with life-altering kratom addiction against those who say they use it without ill effects to combat opioid use or relieve pain. asserted
they → disclose → pain
Indeed, McCurdy’s research focuses on developing kratom’s dominant chemical compound into a pharmaceutical to treat addiction. asserted
research → focus → addiction
That work has been funded by the federal government, which has poured an estimated $100 million in grants into the research. asserted
which → fund → research
Such funding could be disrupted if kratom is declared illegal. uncertain
kratom → disrupt → ?
McCurdy told ProPublica that he has accepted invitations to speak to policymakers because “decisions about kratom should be informed by the best available science.” asserted
decisions → tell → science
Reimbursed travel expenses don’t influence the “substance” of his presentations or his “scientific conclusions,” he said. asserted
he → reimburse → presentations
“My views on kratom are based on more than two decades of scientific research,” he said. asserted
he → base → research
“They are my own and are not dictated by the American Kratom Association or any other outside organization.” asserted
They → dictate → Association
Those advocating for restrictions on kratom contend that as McCurdy testifies, publishes research or provides public information, he should be more forthright about his relationship with the kratom industry. asserted
he → advocate → industry
Jennifer Brandt, a Virginia pharmacist who advocates for a total ban on kratom sales, was the first to file records requests with the University of Florida for McCurdy’s correspondence. asserted
who → advocate → correspondence
She has subsequently asked a medical journal to append corrections listing his ties to the lobbying group. asserted
She → ask → group
“I’m really confused on where science ends and lobbying begins,” she said of McCurdy. asserted
she → ’m → McCurdy
McCurdy’s work opposing the criminalization of kratom started as early as 2018. asserted
work → oppose → 2018
That year, he joined with other scientists — including the AKA’s lead science consultant — to convince the Drug Enforcement Administration not to classify kratom as a Schedule I narcotic. asserted
he → join → narcotic
The designation, reserved for drugs with no medical purpose and high abuse potential, would make kratom illegal. asserted
kratom → reserve → purpose
The scientists said in a letter to federal regulators that it would also “severely hinder” their research into possible therapeutic uses. asserted
it → say → uses
In a paper, McCurdy argued that scheduling kratom would erect new regulatory hurdles to studying the leaf and dissuade funders from supporting it. asserted
scheduling → argue → it
The effort to schedule kratom was halted during the first Trump administration. asserted
effort → schedule → administration
However, the association’s fight continued as it worked to convince state lawmakers to explicitly legalize kratom by regulating its sale. asserted
it → continue → sale
McCurdy also became a key player in this effort, according to emails obtained by ProPublica through public records requests to the University of Florida. uncertain
McCurdy → become → Florida
While the group’s membership is made up of kratom users, its lobbying efforts are funded by manufacturers and vendors. asserted
efforts → make → manufacturers
It spends about $2.5 million a year on lobbying. asserted
It → spend → lobbying
In 2023, at the AKA’s request, McCurdy briefed the United Nations Commission on Narcotic Drugs, which regularly considers kratom regulation. asserted
which → brief → regulation
He conducted the briefing remotely and did not travel to the annual meeting in Vienna that year. asserted
He → conduct → Vienna
…and 64 more, not listed.
💬Give feedback
🕘History 🎫Support